C11ORF58 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.561800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.078400E-01
Normal-vs-Stage2
3.309600E-01
Normal-vs-Stage3
7.241900E-02
Normal-vs-Stage4
6.120200E-01
Stage1-vs-Stage2
8.384800E-01
Stage1-vs-Stage3
1.409360E-01
Stage1-vs-Stage4
6.236800E-01
Stage2-vs-Stage3
2.775600E-01
Stage2-vs-Stage4
5.687800E-01
Stage3-vs-Stage4
1.696190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.680400E-01
Normal-vs-AfricanAmerican
4.632400E-01
Normal-vs-Asian
1.156050E-01
Caucasian-vs-AfricanAmerican
8.317800E-01
Caucasian-vs-Asian
1.717030E-01
AfricanAmerican-vs-Asian
2.827000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.272600E-01
Normal-vs-Female
2.631600E-01
Male-vs-Female
9.059600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.475190E-01
Normal-vs-Age(41-60Yrs)
7.843200E-01
Normal-vs-Age(61-80Yrs)
2.192800E-01
Normal-vs-Age(81-100Yrs)
5.364400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.558400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.598000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.828200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.561800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.676800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.419400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.110960E-01
Normal-vs-Daily Drinker
1.003750E-01
Normal-vs-Weekly Drinker
7.174200E-02
Normal-vs-Occasional Drinker
9.469400E-01
Normal-vs-Social Drinker
4.623400E-01
Non Drinker-vs-Daily Drinker
6.687000E-01
Non Drinker-vs-Weekly Drinker
3.600200E-01
Non Drinker-vs-Occasional Drinker
1.213970E-02
Non Drinker-vs-Social Drinker
2.372000E-01
Daily Drinker-vs-Weekly Drinker
6.212000E-01
Daily Drinker-vs-Occasional Drinker
1.142180E-02
Daily Drinker-vs-Social Drinker
1.676980E-01
Weekly Drinker-vs-Occasional Drinker
1.150300E-02
Weekly Drinker-vs-Social Drinker
1.075160E-01
Occasional Drinker-vs-Social Drinker
2.877400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.366200E-02
Normal-vs-Grade 2
3.869800E-02
Normal-vs-Grade 3
2.214100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.110600E-01
Grade 1-vs-Grade 3
4.757200E-01
Grade 1-vs-Grade 4
8.366200E-02
Grade 2-vs-Grade 3
9.180600E-01
Grade 2-vs-Grade 4
3.869800E-02
Grade 3-vs-Grade 4
2.214100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.746400E-01
Normal-vs-NonDiabetic
3.413800E-01
Diabetic-vs-NonDiabetic
5.600400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.633700E-02
Normal-vs-NoPancreatitis
3.508800E-01
Pancreatitis-vs-NoPancreatitis
4.706200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.161600E-01
Normal-vs-N1
3.532000E-01
N0-vs-N1
5.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.444600E-01
Normal-vs-TP53-NonMutant
4.535400E-01
TP53-Mutant-vs-TP53-NonMutant
4.481000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
